Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04215146
Title A Study to Assess Overall Response Rate by Inducing an Inflammatory Phenotype in Metastatic BReast cAnCEr With the Oncolytic Reovirus PeLareorEp in CombinaTion With Anti-PD-L1 Avelumab and Paclitaxel - BRACELET-1 Study
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Oncolytics Biotech

Her2-receptor negative breast cancer



Avelumab + Paclitaxel + Pelareorep

Paclitaxel + Pelareorep

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.